Quoc-Dien Trinh, MD, MBA, presented “Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color” at the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.
How to cite: Trinh, Quoc-Dien. “Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color” October 2024. Accessed Mar 2025. https://grandroundsinurology.com/empowering-communities-fostering-prostate-cancer-awareness-and-resilience-among-men-of-color/
Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color – Summary
Quoc-Dien Trinh, MD, MBA, a urologist specializing in prostate cancer at Brigham and Women’s Hospital, and an associate professor at Harvard Medical School, delivers a 13-minute presentation discussing community outreach and efforts to address racial disparities in prostate cancer outcomes. He highlights how barriers such as mistrust, transportation challenges, and inequitable access to care contribute to significant disparities in prostate cancer mortality rates between Black and White men.
The Mass General Brigham Prostate Cancer Outreach Initiative streamlines complex diagnostic processes and ensures follow-up for abnormal PSA results, particularly aiding underserved populations. Community engagement events, conducted in accessible settings like libraries and churches, are pivotal in rebuilding trust and educating communities. Preliminary results are promising. Expansion plans aim to broaden the safety net to cover the full spectrum of care and incorporate other urological conditions.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Quoc-Dien Trinh, MD, MBA, serves as the Chair of the Department of Urology at the University of Pittsburgh School of Medicine, and as the Chair of Urology at the University of Pittsburgh Medical Center. Dr. Trinh completed his medical degree and a residency in urology at the Université de Montréal in Montreal, Canada, followed by a fellowship in minimally invasive urologic oncology at the Vattikuti Urology Institute in Detroit, Michigan, and an Executive MBA at HEC Paris, where he was awarded for Best Capstone Memoir.
Dr. Trinh specializes in minimally invasive treatments for prostatic diseases, and is an expert in robotic prostate surgery, having performed over 1,500 robotic radical and simple prostatectomies. Dr. Trinh’s research focuses on health equity and outcomes in cancer care delivery and has received funding from the American Cancer Society, the Conquer Cancer Foundation, and the Department of Defense. He has authored over 600 peer-reviewed articles, editorials, and book chapters.
A globally recognized urological surgeon-scientist, Dr. Trinh has been honored with the 2021 Outstanding Citizenship Award from Brigham and Women’s Hospital and the 2022 American Urological Association Young Urologist of the Year award for New England. He is recognized as a Castle Connolly Top Doctor and a Top Asian American Pacific Islander Doctor. He is fluent in English, French, and Vietnamese.
